First Trust Advisors LP Ngm Biopharmaceuticals Inc Transaction History

First Trust Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$13.81 - $18.6 $330,059 - $444,540	-23,900 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$17.26 - $22.02 $412,514 - $526,278	23,900 New	23,900 $423,000
Q3 2021 Nov 15, 2021	SELL	$20.15 - $26.19 $393,952 - $512,040	-19,551 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$15.06 - $30.03 $1.23 Million - $2.46 Million	-81,995 Reduced 80.75%	19,551 $386,000
Q1 2021 May 14, 2021	BUY	$24.99 - $31.93 $2.54 Million - $3.24 Million	101,546 New	101,546 $2.95 Million
Q4 2020 Feb 02, 2021	SELL	$16.21 - $31.44 $1.12 Million - $2.17 Million	-69,009 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$15.59 - $19.97 $1.08 Million - $1.38 Million	69,009 New	69,009 $1.1 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.